Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024
Co-Diagnostics (CODX) announced its participation in MEDICA 2024, the world's largest medical B2B trade fair, scheduled for November 11-14 in Düsseldorf, Germany. The event attracts 83,000 visitors and over 5,300 exhibitors from nearly 70 countries.
The company will showcase its PCR diagnostic products and Co-Primers® technology at Booth #3 D15-1. Additionally, they will deliver a presentation titled 'Advancing POC/OTC Diagnostics: Innovations in Test Development for the Co-Dx PCR Platform' on November 13 at 12:05 PM CET in Hall 8A Booth G40. The presentation will focus on their upcoming Co-Dx PCR platform, which is currently under FDA review.
Co-Diagnostics (CODX) ha annunciato la sua partecipazione a MEDICA 2024, la più grande fiera commerciale B2B del settore medico al mondo, in programma dal 11 al 14 novembre a Düsseldorf, Germania. L'evento attira 83.000 visitatori e oltre 5.300 espositori provenienti da quasi 70 paesi.
L'azienda presenterà i suoi prodotti diagnostici PCR e la tecnologia Co-Primers® allo stand n. 3 D15-1. Inoltre, terranno una presentazione dal titolo 'Avanzare nei Diagnostici POC/OTC: Innovazioni nello Sviluppo dei Test per la Piattaforma Co-Dx PCR' il 13 novembre alle 12:05 CET nel padiglione 8A, stand G40. La presentazione si concentrerà sulla loro prossima piattaforma Co-Dx PCR, attualmente in fase di revisione da parte della FDA.
Co-Diagnostics (CODX) anunció su participación en MEDICA 2024, la feria comercial B2B más grande del mundo en el sector médico, programada para el 11 al 14 de noviembre en Düsseldorf, Alemania. El evento atrae a 83,000 visitantes y más de 5,300 expositores de casi 70 países.
La compañía mostrará sus productos de diagnóstico PCR y la tecnología Co-Primers® en el stand #3 D15-1. Además, ofrecerán una presentación titulada 'Avanzando en Diagnósticos POC/OTC: Innovaciones en el Desarrollo de Pruebas para la Plataforma Co-Dx PCR' el 13 de noviembre a las 12:05 PM CET en el Hall 8A Booth G40. La presentación se centrará en su próxima plataforma Co-Dx PCR, que actualmente está bajo revisión de la FDA.
Co-Diagnostics (CODX)는 세계 최대의 B2B 의료 박람회인 MEDICA 2024에 참가할 것이라고 발표했습니다. 이 행사는 11월 11일부터 14일까지 독일 뒤셀도르프에서 개최됩니다. 이 이벤트는 83,000명의 방문객과 거의 70개국에서 온 5,300명이 넘는 전시업체를 끌어들입니다.
회사는 Booth #3 D15-1에서 PCR 진단 제품과 Co-Primers® 기술을 선보일 예정입니다. 또한, 11월 13일 오후 12:05 CET에 Hall 8A Booth G40에서 'POC/OTC 진단 향상: Co-Dx PCR 플랫폼을 위한 테스트 개발 혁신'이라는 제목의 발표를 진행할 것입니다. 이 발표는 현재 FDA의 검토 중인 새로운 Co-Dx PCR 플랫폼에 초점을 맞출 것입니다.
Co-Diagnostics (CODX) a annoncé sa participation à MEDICA 2024, le plus grand salon B2B médical au monde, prévu du 11 au 14 novembre à Düsseldorf, en Allemagne. L'événement attire 83 000 visiteurs et plus de 5 300 exposants de près de 70 pays.
L'entreprise présentera ses produits de diagnostic PCR et la technologie Co-Primers® au Stand #3 D15-1. De plus, elle fera une présentation intitulée 'Faire avancer les diagnostics POC/OTC : Innovations dans le développement de tests pour la plateforme Co-Dx PCR' le 13 novembre à 12h05 CET dans le Hall 8A, stand G40. La présentation se concentrera sur leur prochaine plateforme Co-Dx PCR, actuellement en cours d'examen par la FDA.
Co-Diagnostics (CODX) hat seine Teilnahme an der MEDICA 2024 bekannt gegeben, der größten B2B-Messe für den Gesundheitsbereich weltweit, die vom 11. bis 14. November in Düsseldorf, Deutschland, stattfindet. Die Veranstaltung zieht 83.000 Besucher und über 5.300 Aussteller aus fast 70 Ländern an.
Das Unternehmen wird seine PCR-Diagnoseprodukte und die Co-Primers®-Technologie am Stand #3 D15-1 präsentieren. Darüber hinaus werden sie am 13. November um 12:05 Uhr MEZ im Saal 8A, Stand G40, eine Präsentation mit dem Titel 'Fortschritte in POC/OTC-Diagnosen: Innovationen in der Testentwicklung für die Co-Dx PCR-Plattform' halten. Die Präsentation wird sich auf ihre kommende Co-Dx PCR-Plattform konzentrieren, die derzeit von der FDA überprüft wird.
- None.
- None.
MEDICA has become the largest medical B2B trade fair in the world, attracting 83,000 visitors and over 5,300 exhibitors from almost 70 countries. The Company expects to use the opportunity to generate increased interest in its suite of PCR in vitro diagnostic and research products for infectious diseases, and to introduce and promote its Co-Primers® technology and applications to a wide audience of international attendees.
The Company's presentation on its upcoming Co-Dx PCR platform*, titled "Advancing POC/OTC Diagnostics: Innovations in Test Development for the Co-Dx PCR Platform" will take place in Hall 8A Booth G40 on Wednesday, November 13 at 12:05 PM CET.
Attendees interested in learning more about the Company and its products, including its upcoming Co-Dx PCR platform, are invited to visit Booth #3 D15-1. To learn more about the fair, visit https://www.medica-tradefair.com.
*The Co-Dx PCR platform (including the Co-Dx PCR Home™, Co-Dx PCR Pro™, mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies and is not available for sale. The Co-Dx PCR Pro instrument and Co-Dx COVID-19 Test are currently under review by the FDA.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medica-trade-fair-in-dusseldorf-germany-on-nov-11-14-2024-302296344.html
SOURCE Co-Diagnostics
FAQ
When is Co-Diagnostics (CODX) presenting at MEDICA 2024?
Where is Co-Diagnostics (CODX) booth located at MEDICA 2024?
What products will Co-Diagnostics (CODX) showcase at MEDICA 2024?
Is the Co-Dx PCR platform currently available for sale?
